18 September 2024
18 September 2024
Vectura will strengthen Phillips Medisize's capabilities with its specialised inhalation expertise.
With 510(k) clearance, MIM Software can now offer Centiloid scaling, an approach to help evaluate patients’ amyloid PET scans.
The company published trial design and preliminary data from the adaptive DBS algorithm for personalised therapy in Parkinson’s disease (ADAPT-PD) trial.
The seriousness of this latest recall can be expected to have a noticeable effect on Medtronic’s laryngoscope sales.
The device's design allows for the treatment of cartilage damage, with or without underlying bone involvement.
The device enables visual perception by processing and transmitting neural signals, even without eyes or an optic nerve.
Eversense 365 is said to be the world's first one-year CGM system, offering a new long-term solution for diabetes management.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
